Category: Allies & Partnerships
Sun Safety Spotlight: Dawn Stringer’s Early-Stage Melanoma Diagnosis
By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 July 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Treatment
Being a child of the 90s, sun safety wasn’t a top priority for Dawn Stringer. “I remember always having pink shoulders,” said Dawn of growing up in sunny Myrtle Beach, South Carolina. Whether from the sun or from tanning beds, having a tan seemed essential.
RARE Registry: Providing Hope Through Innovation
26 July 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Each year approximately 5,000 patients are diagnosed with acral or mucosal melanoma. These rare melanoma subtypes arise in non-sun exposed areas and are not believed to be caused by UV damage. Due to the relative obscurity of these rare subtypes, patients face mounting challenges ranging from late diagnoses, lack of support,...
MRA's Latest Research Report: We Are Melanoma Research
19 July 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Each year, the Melanoma Research Alliance brings together melanoma thought leaders from across the global research community to exchange ideas, share recent scientific successes and hurdles, forge new collaborations, and connect with the patient advocate community.
Stage 4 Mucosal Melanoma to No Evidence of Disease: Dane Thorp's Journey
By Renee Orcione, MRA Digital Engagement & Communications Manager | 26 June 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment
“I can’t hide the fact that I had melanoma,” said Stage 4 mucosal melanoma survivor Dane Thorp. “And when I share my story with others, I always emphasize the importance of being your own advocate.”
What to Know About the Different Types of Cutaneous Melanoma
21 June 2024 In Allies & Partnerships, Prevention, Science, Treatment
Cutaneous melanoma is the most common form of melanoma, accounting for roughly 90% of all diagnoses. Cutaneous melanoma typically develops on skin that receives UV exposure. Other types of melanoma include acral, uveal, and mucosal melanoma – these are known as rare melanoma subtypes and are not believed to be...
AI and Melanoma: Innovation for the Future
17 June 2024 In Allies & Partnerships, Prevention, Science, Treatment
“Artificial intelligence (AI) is going to transform how we diagnose, treat, and eventually overcome melanoma,” says Dr. Veronica Rotemberg, Director, Dermatology Imaging Informatics Program at Memorial Sloan Kettering Cancer Center.
Melanoma Awareness Month 2024: In Case You Missed It
By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 May 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Throughout the last 31 days, the entire melanoma community has come together to recognize Melanoma Awareness Month. The community heard from leading experts in the field, connected with other patient advocates, and spread awareness of melanoma and the importance of prevention, early detection, and the impact of research.
Reflecting on Melanoma Awareness Month and Understanding Your Risk for Melanoma
30 May 2024 In Allies & Partnerships, Prevention, Science
Melanoma Awareness Month serves as an important time to reflect on the impact that melanoma has on so many lives. It is also a time to raise awareness of its dangers, who may be at higher risk, and how to prevent and detect it.
Kelly McWhinney's Melanoma Journey of Perseverance and Perspective
By Renee Orcione, MRA Digital Engagement & Communications Manager | 13 May 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment
In March of 2022, Kelly McWhinney was a busy mother to her one and two-year-old daughters Mia and Blakely. Life was as hectic as expected for the 27-year-old, but when she noticed that a mole on her back was suddenly changing, she decided to call her dermatologist.
Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research
1 May 2024 In Allies & Partnerships, News, Prevention, Science, Treatment
The Melanoma Research Alliance (MRA), the world’s leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe. Melanoma, the deadliest form of skin cancer, remains a public...